Bayesian Capital Management’s HCA Healthcare HCA Stock Holding History

Bayesian Capital Management’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,973	Closed	-$1.03M	–	686
2025 Q1	$1.03M	Buy	+2,973	New	+$956K	0.17%	160
2022 Q1	–	Sell	-5,774	Closed	-$1.48M	–	829
2021 Q4	$1.48M	Buy	+5,774	New	+$1.41M	0.47%	50
2021 Q2	–	Sell	-3,000	Closed	-$565K	–	503
2021 Q1	$565K	Buy	+3,000	New	+$529K	0.13%	206
2020 Q4	–	Sell	-2,700	Closed	-$337K	–	545
2020 Q3	$337K	Sell	2,700 -19,600	-88%	-$2.43M	0.08%	320
2020 Q2	$2.16M	Buy	22,300 +11,200	+101%	+$1.16M	0.48%	38
2020 Q1	$997K	Buy	+11,100	New	+$1.44M	0.22%	133
2019 Q2	–	Sell	-3,700	Closed	-$482K	–	580
2019 Q1	$482K	Sell	3,700 -8,500	-70%	-$1.14M	0.09%	297
2018 Q4	$1.52M	Buy	12,200 +5,900	+94%	+$792K	0.31%	77
2018 Q3	$876K	Sell	6,300 -1,800	-22%	-$224K	0.14%	203
2018 Q2	$831K	Sell	8,100 -9,387	-54%	-$950K	0.19%	142
2018 Q1	$1.7M	Buy	+17,487	New	+$1.7M	0.43%	39
2017 Q2	–	Sell	-3,161	Closed	-$281K	–	504
2017 Q1	$281K	Buy	+3,161	New	+$264K	0.13%	269

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bayesian Capital Management's HCA Position: Q2 2025 in Review

Bayesian Capital Management sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 2,973 shares — an estimated $1.03M sold.

Bayesian Capital Management first reported a position in HCA in Q1 2017 and held it in 12 quarters. The position peaked at $2.16M in Q2 2020. 1,250 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

Bayesian Capital Management reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
Bayesian Capital Management sold 2,973 HCA Healthcare shares in Q2 2025, an estimated $1.03M.
Bayesian Capital Management first reported a position in HCA Healthcare in Q1 2017 and held it in 12 quarters.
Bayesian Capital Management's HCA Healthcare position peaked at $2.16M in Q2 2020.
1,250 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.